直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

At the PTAB Blog

PTAB Issues Notice of Proposed Rulemaking for Motions to Amend

March 1, 2024

Authored and Edited by Kai Rajan; Joshua L. Goldberg

On Friday, March 1, 2024, the Patent and Trademark Office issued a Notice of Proposed Rulemaking relating to motions to amend before the Patent Trial and Appeal Board. The Proposed Rules, if implemented, will make permanent certain provisions of the current Pilot Program for motions to amend.  

The Pilot Program allows patent owners to request preliminary guidance from the PTAB, and change the substitute claims in a revised Motion to Amend after receiving the preliminary guidance and initial invalidity grounds from the petitioner, effectively providing the patent owner with two attempts to amend the claims. Motions to amend that are not filed under the Pilot Program do not receive preliminary guidance from the PTAB, and are effectively a one-shot attempt at filing substitute claims that satisfy all threshold requirements for amended claims and are patentable over petitioner’s opposition grounds. 

Under the Proposed Rules, patent owners will be able to request preliminary guidance like in the Pilot Program. In response to such guidance, the patent owner will have the option to file a revised motion to amend without pre-authorization, or to reply directly to the preliminary guidance. In addition to opposing the original motion to amend and any revised motion, the petitioner will also be allowed to respond to the preliminary guidance. 

The Notice also clarifies some lesser-known provisions of the Pilot Program. First, the Office proposes to apply a preponderance of the evidence standard to any new ground of unpatentability that the PTAB raises in its preliminary guidance. Second, the Notice reaffirms the PTAB’s authority to have the Office conduct its own prior art search of the substitute claims at the PTAB’s request, and the search results may be added to the record. The PTAB may also solicit examination assistance to identify new matter or evaluate other statutory and regulatory requirements. The PTAB had this authority under the Pilot Program, but the Office indicated that to date, the PTAB has not solicited the assistance of patent examiners in addressing a motion to amend. Third, the Notice clarifies that the PTAB has discretion to extend the deadline for a final written decision by up to six months for good cause, which may include complex issues or to accommodate additional papers such as a requested examination search report.  

The Notice is scheduled to publish in the Federal Register on Monday, March 4, 2024. Assuming publication occurs as scheduled, the Office will accept comments and feedback from the public through May 3, 2024. 

Tags

motions to amend (MTA)

Related Practices

Global IP Enforcement, Litigation, and Trials

Patent Litigation and Trials

Patent Office Invalidation Proceedings

PTAB Invalidation Proceedings: IPR and PGR

Related Offices

Washington, DC

Contacts

Kai Rajan
Of Counsel
Washington, DC
+1 202 408 4307
Email
Joshua L. Goldberg
Partner
Reston, VA
+1 202 408 6092
Email

Copyright © 2024 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP. 


DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. One of our lawyers will be happy to discuss the possibility of representation with you. Additional disclaimer information.

Related Insights

Charitable

Bridges From School to Work Gala 2026

June 22, 2026

Washington, DC

Charitable

Banding Together 2026

June 18, 2026

Washington, DC

At the PTAB Blog

Consistency Is Key – USPTO Issues Three New Informative Decisions

May 29, 2026

At the PTAB Blog

Discretion All the Way Down: USPTO Uses a Discretionary IPR Denial to Justify a    
§ 325(d) EPR Denial

May 28, 2026

Articles

Colorado Replaces Landmark AI Act: An Overview of the New SB 26-189 Framework

May 26, 2026

At the PTAB Blog

IPR and PGR Statistics for Final Written Decisions Issued in March and April 2026

May 26, 2026

At the PTAB Blog

Claim Disclaimer Derails Instituted IPR in Freightcar America

May 26, 2026

At the PTAB Blog

Before the Holding, the Message: Director Squires Uses Magnolia Medical to Outline PTAB Discretionary Denial Policy Changes

May 20, 2026

Conference

19th Annual Forum on Pharma & Biotech Patent Litigation in Europe

May 19-20, 2026

Amsterdam

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP